Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stool Tests Rapidly Predict H. pylori Antibiotic Resistance

By LabMedica International staff writers
Posted on 11 Nov 2021
Helicobacter pylori eradication rates have declined in concert with rising antimicrobial resistance worldwide. More...
There is a need for rapid accurate, reliable antibiotic resistance testing, especially in refractory cases.

Culture-based susceptibility testing requires endoscopic gastric biopsy, with resultant inconvenience and costs. Molecular testing using next generation sequencing (NGS) of stool potentially allows rapid prediction of resistance to all six commonly used antimicrobials.

Clinical Scientists at the Rhode Island Hospital (Providence, RI, USA) and their colleagues compared the accuracy of NGS with gastric biopsy for identifying H. pylori antibiotic resistance in 262 patients scheduled for upper endoscopy at four clinical practices. Two gastric biopsies were taken for NGS and a spontaneously passed stool specimen was also obtained within two weeks of endoscopy, but before starting treatment for H. pylori. H. pylori was confirmed in biopsies by PCR followed by NGS. H pylori in stools was confirmed by fecal antigen test and PCR. Stool samples positive by at least two stool tests were also examined by NGS to predict resistance to amoxicillin, clarithromycin, metronidazole, tetracycline, levofloxacin, and rifabutin.

The investigators reported that 73 (29%) patients were H. pylori positive by stool testing; two had insufficient gastric DNA for analysis. Of the 71 evaluable cases identical results for stool and biopsy samples were obtained for all six antibiotics in 65 (91.5%). In six cases there was mismatch between gastric and stool results; in four cases this was due to one antibiotic-associated mutation difference. For 70.4% of gastric biopsies, there was at least one resistance-associated mutation. Only 21 (29.6%) had no mutations. Results for stool were similar: 50 cases (68.5%) had at least one resistance-associated mutation and 23 (31.5%) had no mutations. The concordance between stool and gastric biopsies for individual antibiotics ranged from 89% (metronidazole) to 100%.

Steven Moss, MD, a gastroenterologist and senior author of the study, said, “Culture-based susceptibility testing requires endoscopic gastric biopsy, with resultant inconvenience and costs. It is now possible to rapidly obtain susceptibility data without endoscopy.”

The authors concluded that profiling H. pylori antibiotic resistance by NGS from stool samples provides rapid results highly comparable to those obtained from gastric biopsies. Using NGS to determine H. pylori antibiotic resistance using stool obviates the cost, inconvenience and risks of endoscopy for patients in whom resistance profiling is needed. The study was presented at the 2021 Virtual Meeting of the American College of Gastroenterology (ACG) held October 22-27, 2021.

Related Links:
Rhode Island Hospital


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Portable Electronic Pipette
Mini 96
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.